NANO Nuclear Energy Inc.

What they do

Nano Nuclear Energy is a nuclear energy and technology company developing smaller, simpler advanced clean energy solutions using proprietary reactor designs and intellectual property. Its principal development focus is the KRONOS MMR Energy System, a high-temperature gas-cooled, TRISO-fueled microreactor, and its portfolio also includes the LOKI MMR reactor and the ZEUS solid core battery reactor. The company states it is pre-revenue and operates across four business lines spanning reactor development, nuclear fuel transportation, the nuclear fuel supply chain, and nuclear consulting services.

Revenue drivers

• Nuclear Reactor Business (KRONOS MMR) — Planned commercial sale and deployment of the KRONOS MMR Energy System; the company allocates the most time and capital here but has generated no revenue and targets commercial launch in the early 2030s.
• LOKI MMR and ZEUS reactors — Portable HTGR and solid core battery reactor designs in the portfolio; development-stage only, with no reported revenue contribution.
• Nuclear fuel transportation and supply chain — Stated ambition in commercial nuclear fuel transportation and the nuclear energy fuel supply chain; no revenue reported to date.
• Nuclear consulting services — Consulting and service support for the nuclear industry described as a business line; immaterial relative to reactor development and not separately quantified in the excerpts.

Recent performance

The company reported a net loss of approximately $10.1 million for the three months ended June 30, 2026 and $25.8 million for the nine months ended June 30, 2026. Revenue for the quarter ended June 30, 2026 was $214,042. Annual net losses widened from $6.3 million in 2023 to $10.2 million in 2024 and $40.1 million in 2025, with operating cash flow of negative $3.9 million, negative $8.5 million and negative $19.6 million, respectively. At June 30, 2026 the company reported total assets of $628.0 million, total liabilities of $12.0 million, shareholder equity of $616.0 million and cash and equivalents of $298.5 million. Accumulated deficit was approximately $83.3 million as of June 30, 2026, up from $57.5 million at September 30, 2025.

Strategy

Management is directing the largest share of time and capital to the KRONOS MMR Energy System, aiming for commercial launch first among its reactors in the early 2030s. On April 2, 2026 the Construction Permit Application for KRONOS MMR deployment at the University of Illinois Urbana-Champaign was submitted to the NRC and accepted for review on May 18, 2026, with the company citing continued progress in that review as of June 25, 2026. The January 10, 2025 acquisition of KRONOS and LOKI assets from Ultra Safe Nuclear Corporation brought five third-party contracts, 38 issued, pending or published patents and 16 trademarks, plus rights to a KRONOS demonstration project. The company also holds rights to the ODIN reactor, which it states it is in the process of selling, and continues to pursue fuel transportation, fuel supply chain and consulting ambitions.

Risks

• Pre-revenue losses — The company has incurred significant operating losses since inception, had an accumulated deficit of $57.5 million at September 30, 2025, and expects losses and negative cash flows to increase.
• No meaningful revenue expected soon — Management states it does not expect to generate revenue unless and until it commercializes its reactors, with first commercial launch targeted for the early 2030s.
• Regulatory approval risk — Commercialization depends on complex nuclear regulatory processes, including the NRC review of the KRONOS MMR Construction Permit Application submitted for the UIUC project.
• Financing risk — Management states the business requires substantial additional funds that may not be available on acceptable terms or at all, and continued solvency depends on obtaining additional financing.

Outlook

Management states it expects the KRONOS MMR to achieve initial operation or research availability around 2030, subject to the NRC review timeline, safety and environmental reviews, construction and commissioning. Commercial launch of the reactor portfolio is targeted for the 2030s, with KRONOS first in the early 2030s, though the company cautions this timeline is subject to regulatory, operational and market uncertainties. No assurance is given that launches will occur in the anticipated timeframes, if at all.